A survey of seven countries has found a striking difference in dialysis reimbursement policies, even when data were adjusted for gross domestic product per capita. Although increased reimbursement is perceived to be a valuable incentive for certain treatments, this perception is not supported by current data and alternative strategies to promote home-based dialysis should be pursued.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study
BMC Nephrology Open Access 15 January 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jain, A. K., Blake, P., Cordy, P. & Garg, A. X. Global trends in rates of peritoneal dialysis. J. Am. Soc. Nephrol. 23, 533–544 (2012).
Vanholder, R. et al. Reimbursement of dialysis: a comparison of seven countries. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2011111094.
Li, P. K. et al. Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Nephrology (Carlton) 16, 53–56 (2011).
Just, P. M. et al. Economic evaluations of dialysis treatment modalities. Health Policy 86, 163–180 (2008).
Li, P. K. & Chow, K. M. Peritoneal dialysis patient selection: characteristics for success. Adv. Chronic Kidney Dis. 16, 160–168 (2009).
Dor, A., Pauly, M. V., Eichleay, M. A. & Held, P. J. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int. J. Health Care Finance Econ. 7, 73–111 (2007).
Kleophas, W. & Reichel, H. International study of health care organization and financing: development of renal replacement therapy in Germany. Int. J. Health Care Finance Econ. 7, 185–200 (2007).
Mendelssohn, D. C., Langlois, N. & Blake, P. G. Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology. Perit. Dial. Int. 24, 531–537 (2004).
Li, P. K. & Szeto, C. C. Success of the peritoneal dialysis programme in Hong Kong. Nephrol. Dial. Transplant. 23, 1475–1478 (2008).
Acknowledgements
The authors' research work is supported in part by the Richard Yu Chinese University of Hong Kong Peritoneal Dialysis Research Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P. K.-T. Li declares that he has acted as Principal Investigator for a clinical trial conducted by Baxter and as a member of a Baxter Trial Advisory Board. He has also received speaker honoraria from Astellas, Baxter, Fresenius and Roche. K. M. Chow declares no competing interests.
Rights and permissions
About this article
Cite this article
Chow, K., Li, PT. Choice of dialysis—what to do with economic incentives. Nat Rev Nephrol 8, 495–496 (2012). https://doi.org/10.1038/nrneph.2012.165
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.165
This article is cited by
-
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
Nature Reviews Nephrology (2017)
-
State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study
BMC Nephrology (2015)
-
Economic evaluation of dialysis therapies
Nature Reviews Nephrology (2014)
